BioAdaptives, Inc. (BDPT)
OTCMKTS · Delayed Price · Currency is USD
0.0030
-0.001775 (-37.17%)
At close: Jun 15, 2026
BioAdaptives Employees
BioAdaptives had 1 employees as of December 31, 2025. The number of employees decreased by 5 or -83.33% compared to the previous year.
Employees
1
Change
-5
Growth
-83.33%
Revenue / Employee
$23,792
Profits / Employee
-$1,471,848
Market Cap
57.34K
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 1 | -5 | -83.33% | 1 | 0 |
| Dec 31, 2023 | 6 | -1 | -14.29% | 3 | 3 |
| Dec 31, 2022 | 7 | 0 | - | 3 | 4 |
| Dec 31, 2021 | 7 | 6 | 600.00% | 3 | 4 |
| Dec 31, 2015 | 1 | - | - | 1 | 0 |
BioAdaptives News
- 26 days ago - BioAdaptives Launches MyndSystem™ Website — The First Supplement Platform Designed to Support Both Daytime Cognitive Performance and Overnight Brain Recovery - GlobeNewsWire
- 5 weeks ago - BioAdaptives, Inc. Launches MyndRenew™ to Complete the 24-Hour Brain Performance Cycle - GlobeNewsWire
- 8 months ago - BioAdaptives® Announces Commercial Launch of MyndMed™ Following Successful Pilot Testing - GlobeNewsWire
- 10 months ago - BioAdaptives' MyndMed™ Receives Full Clearance from TruShield™, Meeting UFC and WADA Standards for Athlete Safety - GlobeNewsWire
- 11 months ago - BioAdaptives Announces National Launch of NeuroRush™ — A Cutting-Edge Adaptogenic Nootropic for Mental Clarity, Focus, and Resilience - GlobeNewsWire
- 1 year ago - BioAdaptives Announces National Launch of Pawpa™ Regen - GlobeNewsWire
- 1 year ago - BioAdaptives® PawPa™ Regen Provides Breakthrough Stem Cell Support for Pets, Backed by Clinically Proven APBAR® Scale Improvements - GlobeNewsWire
- 1 year ago - Zeranovia(TM) Weight Loss Product Shows Promising Results in Dosage Trial - GlobeNewsWire